Eyepoint Pharmaceuticals Inc Net Asset Quality Index
Eyepoint Pharmaceuticals Inc net asset quality index. Eyepoint Pharmaceuticals Inc (EYPT) has a Net Asset Quality Index of 79.5% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $251.69 Million minus total liabilities of $51.51 Million yields net assets of $200.18 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Eyepoint Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Eyepoint Pharmaceuticals Inc (2000–2024)
Net asset quality index of Eyepoint Pharmaceuticals Inc from 2000 to 2024. This chart shows how Eyepoint Pharmaceuticals Inc's Net Asset Quality Index has evolved across 24 annual periods from 2000 to 2024. As of September 2025, the index stands at 79.5%, representing net assets of $200.18 Million against total assets of $251.69 Million USD. Check Eyepoint Pharmaceuticals Inc (EYPT) strategic asset index to assess the company's strategic physical and investment asset allocation.
Eyepoint Pharmaceuticals Inc Net Asset Quality Index by Year (2000–2024)
Eyepoint Pharmaceuticals Inc net asset quality index by year from 2000 to 2024. The table below presents the year-by-year Net Asset Quality Index for Eyepoint Pharmaceuticals Inc from 2000 to 2024, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see EYPT stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 80.4% | $336.50 Million | $418.46 Million | $81.96 Million | ▲ +5.4 pp |
| 2023 | 75.0% | $266.32 Million | $355.18 Million | $88.86 Million | ▲ +21.5 pp |
| 2022 | 53.4% | $96.37 Million | $180.36 Million | $83.99 Million | ▼ -16.6 pp |
| 2021 | 70.0% | $184.38 Million | $263.37 Million | $78.99 Million | ▲ +49.8 pp |
| 2020 | 20.2% | $18.54 Million | $91.72 Million | $73.18 Million | ▲ +8.8 pp |
| 2019 | 11.4% | $8.33 Million | $72.97 Million | $64.64 Million | ▼ -4.9 pp |
| 2018 | 16.3% | $11.69 Million | $71.67 Million | $59.98 Million | ▼ -55.1 pp |
| 2017 | 71.4% | $13.34 Million | $18.68 Million | $5.34 Million | ▲ +5.4 pp |
| 2016 | 66.0% | $20.88 Million | $31.62 Million | $10.74 Million | ▼ -6.2 pp |
| 2015 | 72.2% | $23.37 Million | $32.37 Million | $9.00 Million | ▲ +6.4 pp |
| 2014 | 65.8% | $14.92 Million | $22.67 Million | $7.75 Million | ▲ +18.4 pp |
| 2013 | 47.4% | $7.70 Million | $16.25 Million | $8.55 Million | ▼ -18.8 pp |
| 2012 | 66.2% | $13.64 Million | $20.60 Million | $6.96 Million | ▼ -13.2 pp |
| 2011 | 79.5% | $37.43 Million | $47.11 Million | $9.68 Million | ▲ +2.6 pp |
| 2010 | 76.8% | $33.04 Million | $43.01 Million | $9.97 Million | ▲ +13.4 pp |
| 2009 | 63.4% | $23.54 Million | $37.10 Million | $13.56 Million | ▲ +7.9 pp |
| 2008 | 55.5% | $21.79 Million | $39.23 Million | $17.44 Million | ▼ -21.0 pp |
| 2007 | 76.5% | $65.91 Million | $86.12 Million | $20.21 Million | ▲ +8.7 pp |
| 2006 | 67.8% | $66.20 Million | $97.60 Million | $31.40 Million | ▼ -29.7 pp |
| 2005 | 97.5% | $60.74 Million | $62.30 Million | $1.56 Million | ▲ +0.0 pp |
| 2004 | 97.5% | $60.74 Million | $62.30 Million | $1.56 Million | ▲ +2.3 pp |
| 2003 | 95.2% | $26.70 Million | $28.05 Million | $1.35 Million | ▲ +7.4 pp |
| 2002 | 87.8% | $4.23 Million | $4.82 Million | $588.38K | ▼ -9.1 pp |
| 2000 | 96.9% | $4.57 Million | $4.72 Million | $145.74K | — |